Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Estimating Population Mean with Known Standard Deviation01:16

Estimating Population Mean with Known Standard Deviation

9.8K
To construct a confidence interval for a single unknown population mean μ, where the population standard deviation is known, we need sample mean as an estimate for μ and we need the margin of error. Here, the margin of error (EBM) is called the error bound for a population mean (abbreviated EBM). The sample mean is the point estimate of the unknown population mean μ.
The confidence interval estimate will have the form as follows:
(point estimate - error bound, point estimate +...
9.8K
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

5.6K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
5.6K
Estimating Population Standard Deviation01:26

Estimating Population Standard Deviation

3.5K
When the population standard deviation is unknown and the sample size is large, the sample standard deviation s is commonly used as a point estimate of σ. However, it can sometimes under or overestimate the population standard deviation. To overcome this drawback, confidence intervals are determined to estimate population parameters and eliminate any calculation bias accurately. However, this only applies to random samples from normally distributed populations. Knowing the sample mean and...
3.5K
Regression Toward the Mean01:52

Regression Toward the Mean

7.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K
Estimating Population Mean with Unknown Standard Deviation01:22

Estimating Population Mean with Unknown Standard Deviation

9.0K
In practice, we rarely know the population standard deviation. In the past, when the sample size was large, this did not present a problem to statisticians. They used the sample standard deviation s as an estimate for σ and proceeded as before to calculate a confidence interval with close enough results. However, statisticians ran into problems when the sample size was small. A small sample size caused inaccuracies in the confidence interval.
William S. Gosset (1876–1937) of the...
9.0K
Confidence Interval for Estimating Population Mean01:25

Confidence Interval for Estimating Population Mean

9.1K
A point estimate of the population mean is obtained from a single sample. Such a point estimate does not represent a population well because it needs to account for variability in the population. Single point estimate can also be biased despite the sample being selected randomly. Thus, a point estimate is often unreliable. A confidence interval is needed to reduce this unreliability.
A confidence interval for the mean is a range of values that provides an estimate of the population mean. As the...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FDA Gene Therapy Approvals (1998-2025): Current Status, Regulatory Evolution, and Future Directions.

Journal of clinical pharmacology·2026
Same author

Editorial: New drugs and future challenges in drug metabolism and transport.

Frontiers in pharmacology·2026
Same author

Regulatory approvals of therapeutic biologics: continuing progress or plateauing out compared with those of small molecules?

Drug discovery today·2025
Same author

Evaluating the status of antibiotic approvals and readiness to combat antimicrobial resistance: What else can we do better?

Drug discovery today·2023
Same author

Physiologically-based pharmacokinetic modeling to inform dosing regimens and routes of administration of rifampicin and colistin combination against Acinetobacter baumannii.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2023
Same author

The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant <i>Acinetobacter baumannii</i>.

Frontiers in microbiology·2022

Related Experiment Video

Updated: Mar 22, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

QT Correction: Using an Observed Regression Factor Applicable to a Population Subset.

Charles Oo1, Suraj S Kalbag

  • 1SunLife Biopharma, Morris Plains, NJ, USA.

Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques
|April 21, 2016
PubMed
Summary

A new power function formula offers a simpler approach to calculating corrected QT interval (QTc) for specific patient groups. This method aids in comparing drug effects and managing cardiac risk in clinical settings.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

17.2K

Related Experiment Videos

Last Updated: Mar 22, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

17.2K

Area of Science:

  • Cardiology
  • Pharmacology
  • Biostatistics

Background:

  • Accurate corrected QT interval (QTc) calculation is crucial for assessing drug effects and cardiac risk.
  • Existing QTc formulas are often complex and their applicability varies across different patient populations.
  • Individualized QTc assessment requires extensive data, making it impractical for initial evaluations.

Purpose of the Study:

  • To address the need for an effective and comprehensible QTc calculation method.
  • To propose a power function approach (QTc = QT/{(RR)a}) using a population-specific regression factor 'a'.
  • To illustrate the utility of this method with distinct patient subsets.

Main Methods:

  • Selection of a power function formula for QTc correction: QTc = QT/{(RR)a}.
  • Determination of a regression factor 'a' tailored to specific population subsets.
  • Application and illustration of the method using two small, defined patient groups (differentiated by age and inpatient/outpatient status).

Main Results:

  • The proposed power function method provides a practical compromise for QTc calculation in specific population subsets.
  • The approach is demonstrated to be implementable in drug development and clinical practice.
  • Illustrative examples show the method's application in age- and status-defined groups.

Conclusions:

  • The power function QTc approach offers a simplified and adaptable method for clinical use.
  • Further research with larger sample sizes and consideration of confounding factors is necessary for comprehensive validation.
  • This method has potential for routine use in drug development and clinical practice for improved cardiac risk assessment.